Aadi Bioscience Stock Analysis

AADI Stock  USD 2.12  0.05  2.30%   
Aadi Bioscience is overvalued with Real Value of 1.84 and Hype Value of 2.11. The main objective of Aadi Bioscience stock analysis is to determine its intrinsic value, which is an estimate of what Aadi Bioscience is worth, separate from its market price. There are two main types of Aadi Bioscience's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Aadi Bioscience's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Aadi Bioscience's stock to identify patterns and trends that may indicate its future price movements.
The Aadi Bioscience stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Aadi Bioscience is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. Aadi Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Aadi Bioscience's ongoing operational relationships across important fundamental and technical indicators.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aadi Bioscience. Also, note that the market value of any Company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment.
For more detail on how to invest in Aadi Stock please use our How to Invest in Aadi Bioscience guide.

Aadi Stock Analysis Notes

About 12.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.51. Some equities with similar Price to Book (P/B) outperform the market in the long run. Aadi Bioscience recorded a loss per share of 2.44. The entity had not issued any dividends in recent years. The firm had 1:15 split on the 27th of August 2021. Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. The company was incorporated in 2007 and is headquartered in Pacific Palisades, California. Aadi Biosciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 67 people. For more info on Aadi Bioscience please contact David Lennon at 424-744-8055 or go to https://aadibio.com.

Aadi Bioscience Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Aadi Bioscience's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Aadi Bioscience or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Aadi Bioscience had very high historical volatility over the last 90 days
Aadi Bioscience has high likelihood to experience some financial distress in the next 2 years
The company reported the previous year's revenue of 24.35 M. Net Loss for the year was (65.77 M) with loss before overhead, payroll, taxes, and interest of (18.78 M).
Aadi Bioscience currently holds about 118.74 M in cash with (59.66 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.65, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Roughly 12.0% of the company shares are held by company insiders
Latest headline from finance.yahoo.com: Is Aadi Bioscience Outperforming Other Medical Stocks This Year

Aadi Bioscience Upcoming and Recent Events

Earnings reports are used by Aadi Bioscience to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Aadi Bioscience previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
26th of March 2024
Upcoming Quarterly Report
View
8th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
26th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Aadi Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 53.28 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Aadi Bioscience's market, we take the total number of its shares issued and multiply it by Aadi Bioscience's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Aadi Profitablity

Aadi Bioscience's profitability indicators refer to fundamental financial ratios that showcase Aadi Bioscience's ability to generate income relative to its revenue or operating costs. If, let's say, Aadi Bioscience is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Aadi Bioscience's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Aadi Bioscience's profitability requires more research than a typical breakdown of Aadi Bioscience's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (2.7) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (2.8) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $2.8.

Technical Drivers

As of the 19th of March, Aadi Bioscience shows the mean deviation of 4.61, and Risk Adjusted Performance of (0.05). Aadi Bioscience technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to break down thirteen technical drivers for Aadi Bioscience, which can be compared to its rivals. Please confirm Aadi Bioscience standard deviation, as well as the relationship between the treynor ratio and potential upside to decide if Aadi Bioscience is priced correctly, providing market reflects its regular price of 2.12 per share. Please also double-check Aadi Bioscience jensen alpha, which is currently at (1.34) to validate the company can sustain itself at a future point.

Aadi Bioscience Price Movement Analysis

Execute Study
The output start index for this execution was nine with a total number of output elements of fifty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Aadi Bioscience middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Aadi Bioscience. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Aadi Bioscience Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Aadi Bioscience insiders, such as employees or executives, is commonly permitted as long as it does not rely on Aadi Bioscience's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Aadi Bioscience insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Aadi Bioscience Predictive Daily Indicators

Aadi Bioscience intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Aadi Bioscience stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Aadi Bioscience Corporate Filings

8K
13th of March 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
F4
4th of March 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
12th of February 2024
Other Reports
ViewVerify
F4
2nd of February 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
F4
2nd of January 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
8K
14th of December 2023
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
F4
7th of December 2023
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
F4
5th of December 2023
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify

Aadi Bioscience Forecast Models

Aadi Bioscience's time-series forecasting models are one of many Aadi Bioscience's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Aadi Bioscience's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Aadi Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Aadi Bioscience prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Aadi shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Aadi Bioscience. By using and applying Aadi Stock analysis, traders can create a robust methodology for identifying Aadi entry and exit points for their positions.
Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. The company was incorporated in 2007 and is headquartered in Pacific Palisades, California. Aadi Biosciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 67 people.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Aadi Bioscience to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Correlation Analysis Now

   

Correlation Analysis

Reduce portfolio risk simply by holding instruments which are not perfectly correlated
All  Next Launch Module
When determining whether Aadi Bioscience offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Aadi Bioscience's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Aadi Bioscience Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Aadi Bioscience Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aadi Bioscience. Also, note that the market value of any Company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment.
For more detail on how to invest in Aadi Stock please use our How to Invest in Aadi Bioscience guide.
Note that the Aadi Bioscience information on this page should be used as a complementary analysis to other Aadi Bioscience's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.

Complementary Tools for Aadi Stock analysis

When running Aadi Bioscience's price analysis, check to measure Aadi Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aadi Bioscience is operating at the current time. Most of Aadi Bioscience's value examination focuses on studying past and present price action to predict the probability of Aadi Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aadi Bioscience's price. Additionally, you may evaluate how the addition of Aadi Bioscience to your portfolios can decrease your overall portfolio volatility.
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Is Aadi Bioscience's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aadi Bioscience. If investors know Aadi will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aadi Bioscience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Aadi Bioscience is measured differently than its book value, which is the value of Aadi that is recorded on the company's balance sheet. Investors also form their own opinion of Aadi Bioscience's value that differs from its market value or its book value, called intrinsic value, which is Aadi Bioscience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aadi Bioscience's market value can be influenced by many factors that don't directly affect Aadi Bioscience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aadi Bioscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if Aadi Bioscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aadi Bioscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.